USSTOCK.TODAY
Market Closed Log in Sign up

Protech Inc(PRTC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today

Halted
Trading Halted Since 2026-06-22: Trading has been halted. It may resume, and prices shown reflect the last trading day.
PRTC
PRTC
Halted
Protech Inc
$17.42
+0.00 +0.00%

Full metrics table

Index ⓘ -P/E ⓘ -EPS (ttm) ⓘ -4.6Insider Own ⓘ -Shs Outstand ⓘ 24.3MPerf Week ⓘ -
Market Cap ⓘ 0.42BForward P/E ⓘ -EPS next Y ⓘ -Insider Trans ⓘ -Shs Float ⓘ -Perf Month ⓘ 4.37%
Enterprise Value ⓘ -PEG ⓘ -EPS next Q ⓘ -Inst Own ⓘ 0.58%Short Float ⓘ -Perf Quarter ⓘ 1.34%
Income ⓘ -P/S ⓘ 91.01EPS this Y ⓘ -Inst Trans ⓘ -Short Ratio ⓘ 0.9Perf Half Y ⓘ 3.75%
Sales ⓘ 0.00BP/B ⓘ 1.35EPS next 5Y ⓘ -ROA ⓘ -Short Interest ⓘ 0.01MPerf YTD ⓘ 4.69%
Book/sh ⓘ 12.91P/C ⓘ -EPS past 3/5Y ⓘ -ROE ⓘ -52W High ⓘ -12.55% ($19.92)Perf Year ⓘ -0.03%
Cash/sh ⓘ -P/FCF ⓘ -Sales past 3/5Y ⓘ -ROIC ⓘ -52W Low ⓘ 20.14% ($14.50)Perf 3Y ⓘ -30.65%
Dividend Est. ⓘ -EV/EBITDA ⓘ -EPS Y/Y TTM ⓘ -312.58%Gross Margin ⓘ -Volatility(W/M) ⓘ 3.75% 4.31%Perf 5Y ⓘ -66.88%
Dividend TTM ⓘ -EV/Sales ⓘ -Sales Y/Y TTM ⓘ -3.44%Oper. Margin ⓘ -ATR (14) ⓘ 0.79Perf 10Y ⓘ -
Dividend Ex-Date ⓘ -Quick Ratio ⓘ -EPS Q/Q ⓘ -Profit Margin ⓘ -RSI (14) ⓘ 51.77Recom ⓘ -
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ -Sales Q/Q ⓘ -38.2%SMA20 ⓘ 0.51% ($17.33)Beta ⓘ 1.15Target Price ⓘ -
Payout ⓘ -Debt/Eq ⓘ -Earnings ⓘ 2026/4/29SMA50 ⓘ 3.4% ($16.85)Rel Volume ⓘ 0Prev Close ⓘ $17.42
Employees ⓘ -LT Debt/Eq ⓘ -EPS/Sales Surpr. ⓘ 6.86% -93.19%SMA200 ⓘ 0.45% ($17.34)Avg Volume(3M) ⓘ 0.01MPrice ⓘ $17.42
IPO ⓘ 2020/11/16Option/Short ⓘ No/NoTrades ⓘ 0Volume ⓘ -Change ⓘ -
Company
PRTC PRTCProtech Inc | NASD | Biotechnology Deep dive

🧬 Prothena (PRTC) is a clinical-stage biopharmaceutical company that discovers and develops new drug candidates based on its proprietary platform and a founded entity model. It maintains a pipeline in the areas of pulmonary fibrosis, oncology, and neuropsychiatry, and is characterized by a structure in which its core assets are spun off into independent subsidiaries to drive value growth.

Quote

Over the past 1 year, roughly in the middle

13% below its 1-year high.

Now $17.42
52w low$14.5052w high$19.92
52W Range54%
Volume ⓘ 0

Traded less than usual. That is 0% of its average volume.

D
Overall · many cautions
We judged 3 of the 8 questions below. 2 need caution.
No data for profitability, growth, earnings, outlook, dividends, or not applicable.
Peer comparison Biotechnology

It ranks #228 of 599 in the industry

Based on market cap of $424M.

FAQ

FAQ

PRTC belongs to the Healthcare sector and operates in the Biotechnology industry.

The market cap of PRTC is approximately $424M, ranking 3,339 within its sector.

PRTC has recorded a 52-week high of $19.92 and a low of $14.50.

Telegram KakaoTalk
Briefs · earnings · signals, first Telegram · KakaoTalk channels